مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,268
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

BENZYDAMINE FOR PROPHYLAXIS OF RADIATION-INDUCED ORAL MUCOSITIS IN HEAD AND NECK CANCERS; A DOUBLE-BLIND CLINICAL TRIAL

Pages

  183-191

Abstract

 Background: This study has been conducted to determine the effect of using oral rinse BENZYDAMINE in prevention of radiation induced MUCOSITIS.Materials and Methods: Patients with head and neck cancers, who referred to Cancer Institute between 2004 and 2005, were enrolled in a double blind clinical trail. They had to receive 15 cc of oral rinse BENZYDAMINE or placebo, four times a day, from the first day of radiotherapy up to the end of the course. The incidence of MUCOSITIS grade 3 or more was evaluated.Results: From 100 patients who were randomized in this trail, 19patients were excluded of the analysis due to minor side-effects of drug, or stopping the radiotherapy. The incidence of MUCOSITIS grade 3 or more was 43.6% among 39 cases in treated group, whereas among 42 cases in placebo group this rate was 78.6 %. The difference was, therefore, significant (P< 0.005). MUCOSITIS grade 3 or more was 1.8 times more frequent in placebo group (Relative Risk=I.8). Also, if the patients did not receive BENZYDAMINE the attributive risk of MUCOSITIS was 35%. After the third week of treatment, the mean grade of MUCOSITIS was more than 2 in the placebo group; but in the BENZYDAMINE group it was less than 2 up to the end of radiotherapy (P<0.001).Conclusion: According to these results it seems that oral rinse BENZYDAMINEis effective, safe, and well-tolerated for prophylactic treatment of radiation-induced oral MUCOSITIS in HEAD AND NECK TUMORS. There is a need to evaluate the efficacy of BENZYDAMINEin another large study in Iran.

Cites

References

  • No record.
  • Cite

    APA: Copy

    KAMIAN, SH., KAZEMIAN, A., AGHILI, M., AMOUZGAR HASHEMI, F., & HADAD, P.. (2008). BENZYDAMINE FOR PROPHYLAXIS OF RADIATION-INDUCED ORAL MUCOSITIS IN HEAD AND NECK CANCERS; A DOUBLE-BLIND CLINICAL TRIAL. RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH), 13(3 (63)), 183-191. SID. https://sid.ir/paper/18214/en

    Vancouver: Copy

    KAMIAN SH., KAZEMIAN A., AGHILI M., AMOUZGAR HASHEMI F., HADAD P.. BENZYDAMINE FOR PROPHYLAXIS OF RADIATION-INDUCED ORAL MUCOSITIS IN HEAD AND NECK CANCERS; A DOUBLE-BLIND CLINICAL TRIAL. RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH)[Internet]. 2008;13(3 (63)):183-191. Available from: https://sid.ir/paper/18214/en

    IEEE: Copy

    SH. KAMIAN, A. KAZEMIAN, M. AGHILI, F. AMOUZGAR HASHEMI, and P. HADAD, “BENZYDAMINE FOR PROPHYLAXIS OF RADIATION-INDUCED ORAL MUCOSITIS IN HEAD AND NECK CANCERS; A DOUBLE-BLIND CLINICAL TRIAL,” RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH), vol. 13, no. 3 (63), pp. 183–191, 2008, [Online]. Available: https://sid.ir/paper/18214/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button